IL1B and Alzheimer disease: Anti-Aβ/anti-CD33 and anti-Aβ/anti-NLRP3 antibodies enhanced Aβ uptake and reduced inflammation (TNF-α, IL-1β) in Tg2576 and 3xTg-AD mice [68,69].